Request Demo
Last update 08 May 2025
BA-1202
Last update 08 May 2025
Overview
Basic Info
Drug Type Bispecific T-cell Engager (BiTE) |
Synonyms |
Target |
Action stimulants, inhibitors |
Mechanism CD3 stimulants(T cell surface glycoprotein CD3 stimulants), CEA inhibitors(Carcinoembryonic antigen inhibitors) |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
2
Clinical Trials associated with BA-1202NCT05909241
A Multicenter, Open-label, Single-arm, Dose Escalation and Expansion Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of BA1202 in Patients With Advanced Solid Tumors
CTR20231656
在晚期实体瘤患者中评价注射用BA1202安全性、耐受性、药代动力学和初步疗效的多中心、开放、单臂、剂量递增和剂量扩展I期临床研究
[Translation] A multicenter, open-label, single-arm, dose-escalation and dose-expansion Phase I clinical study to evaluate the safety, tolerability, pharmacokinetics and preliminary efficacy of BA1202 for injection in patients with advanced solid tumors
100 Clinical Results associated with BA-1202
Login to view more data
100 Translational Medicine associated with BA-1202
Login to view more data
100 Patents (Medical) associated with BA-1202
Login to view more data
100 Deals associated with BA-1202
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Advanced Malignant Solid Neoplasm | Phase 1 | China | 16 Aug 2023 | |
| Colorectal Cancer | Phase 1 | China | - | |
| Pancreatic Ductal Adenocarcinoma | Phase 1 | China | - | |
| Pancreatic Ductal Carcinoma | Preclinical | China | 18 Jul 2022 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Biosimilar
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free